Bioconjugation Insights

BIOCONJUGATION INSIGHTS

LAUNCHING SOON

Welcome to Bioconjugation Insights!

AIMS & SCOPE

The convergence of biology and chemistry has shaped current drug discovery and development, bridging the gap between biological processes and chemical interventions. Nowhere is this key trend more perfectly embodied than in the burgeoning field of bioconjugation.

Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.

CONTENT

Click here for the Editorial Calendar.

Bioconjugation Insights will feature specifically commissioned new content while exploring all major bioconjugation technologies and modalities, including but not limited to:

  • Antibody-drug conjugates (ADCs)
  • Antibody-oligonucleotide conjugates (AOCs)
  • Bispecific ADCs (BsADCs)
  • Conjugated vaccines
  • Diagnostic and imaging tools
  • Enzyme conjugates
  • Nanoparticle conjugates
  • Polymer conjugates – including PEGylation
  • Protein and peptide conjugates (PPCs)
  • Radioconjugates
  • Targeted drug delivery
  • Theranostics

These and other bioconjugation technologies will be examined across a wide range of applications and functionals areas, including:

  • Discovery, design, and engineering
  • Manufacturing and supply chain
  • Analytical development
  • Preclinical, translational and clinical R&D
  • Regulation
  • Financing and market access

BioInsights’ signature blend of in-depth scientific and technical detail with ‘big picture’ strategic analysis provides the perfect platform to contextualize recent progress, address current issues, and share insights into future directions for this rapidly developing sector.

TARGET AUDIENCE

Bioconjugation Insights will cater to both current experts and new entrants in the bioconjugation field. This includes professionals in academia, pharma, biotech, and the tools and services sectors and external stakeholders such as analysts, investors, regulators, payers, HTAs, NGOs, and patient advocacy groups.

CONTACT

For more information or to discuss thought leadership and lead generation opportunities, contact Nicola McCall at n.mccall@insights.bio, or download the Media Kit.